Onxeo SA

Onxeo SA, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions worldwide. The company offers Beleodaq for the treatment of peripheral T-cell lymphoma. Show More...

Website https://www.onxeo.com
Sector Healthcare
Industry Biotechnology
Last Quote 0.07 EUR
Last Updated 29-05-2025
External Links Yahoo Finance Morningstar Ratios
Interest Coverage

The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia

	2010-12	2011-12	2012-12	2013-12	2014-12	2015-12	2016-12	2017-12	2018-12	2019-12	TTM
Earnings Per Share EUR	0.19	-0.83	-0.65	-0.74	-0.19	-0.48	-0.48	-1.17	-0.18	-0.55	-0.55
Dividends EUR
Payout Ratio % *
Shares Mil	15.0	18.0	18.0	21.0	41.0	41.0	47.0	51.0	53.0	61.0	61.0
Book Value Per Share * EUR	1.87	0.58	0.85	0.36	1.94	2.73	2.0	1.91	0.79	0.64	0.28
Free Cash Flow Per Share * EUR	0.22	-1.12	-0.63	-0.61	-0.61	-0.34	-0.56	-0.37	-0.44	-0.13
Return on Assets %	11.79	-48.41	-41.1	-76.86	-9.07	-13.8	-17.83	-58.15	-13.3	-66.87	-66.87
Financial Leverage (Average)	1.4	1.49	1.88	2.39	1.25	1.26	1.33	1.57	1.39	2.19	2.19
Return on Equity %	17.77	-70.04	-66.67	-159.75	-11.9	-17.27	-23.03	-82.06	-19.73	-107.76	-107.76
Return on Invested Capital %	19.1	-68.27	-66.26	-158.46	-11.59	-17.61	-23.76	-81.33	-18.4	-82.94	-82.94
Interest Coverage	13.28	-42.41	-123.21	-52.33	-0.75	-17.06	-49.59	-58.81	-9.76	-33.77	-33.77
Current Ratio	4.23	4.57	3.35	2.41	4.87	3.93	2.97	1.64	2.43	1.82	1.82
Quick Ratio	4.22	4.58	2.77	2.41	4.53	3.29	2.5	1.34	1.91	1.47	1.47
Debt/Equity										0.43	0.43